Kristina Jansen
Publications
- 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
Weidemann, S., Gorbokon, N., Lennartz, M., Hube-Magg, C., Fraune, C., Bernreuther, C., Clauditz, T. S., Jacobsen, F., Jansen, K., Schmalfeldt, B., Wölber, L., Paluchowski, P., Berkes, E., Heilenkötter, U., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Simon, R., Krech, T., Marx, A., Burandt, E. & Lebok, P., 01.02.2023, In: APPL IMMUNOHISTO M M. 31, 2, p. 77-83 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2022
DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer
Jansen, K., Kluth, M., Blessin, N. C., Hube-Magg, C., Neipp, M., Mofid, H., Lárusson, H., Daniels, T., Isbert, C., Coerper, S., Ditterich, D., Rupprecht, H., Goetz, A., Bernreuther, C., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Burandt, E., Perez, D., Izbicki, J. R., Jacobsen, F., Clauditz, T. S., Marx, A. H. & Krech, T., 08.2022, In: HISTOL HISTOPATHOL. 37, 8, p. 739-748 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours
Meiners, J., Jansen, K., Gorbokon, N., Büscheck, F., Luebke, A. M., Kluth, M., Hube-Magg, C., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Menz, A., Jacobsen, F., Clauditz, T., Sauter, G., Uhlig, R., Wilczak, W., Izbicki, J., Perez, D., Minner, S., Burandt, E., Krech, T., Marx, A., Simon, R. & Steurer, S., 03.12.2021, In: BIOMEDICINES. 9, 12, 1831.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples
Jansen, K., Farahi, N., Büscheck, F., Lennartz, M., Luebke, A. M., Burandt, E., Menz, A., Kluth, M., Hube-Magg, C., Hinsch, A., Höflmayer, D., Weidemann, S., Fraune, C., Möller, K., Lebok, P., Sauter, G., Simon, R., Uhlig, R., Wilczak, W., Jacobsen, F., Minner, S., Krech, R., Clauditz, T., Bernreuther, C., Dum, D., Krech, T., Marx, A. & Steurer, S., 12.2021, In: PATHOL RES PRACT. 228, 153663.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness
Weidemann, S., Perez, D., Izbicki, J. R., Neipp, M., Mofid, H., Daniels, T., Nahrstedt, U., Jacobsen, F., Bernreuther, C., Simon, R., Steurer, S., Burandt, E., Marx, A. H., Krech, T., Clauditz, T. S. & Jansen, K., 10.2021, In: CANCER INVEST. 39, 9, p. 711-720 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors
Weidemann, S., Gagelmann, P., Gorbokon, N., Lennartz, M., Menz, A., Luebke, A. M., Kluth, M., Hube-Magg, C., Blessin, N. C., Fraune, C., Möller, K., Bernreuther, C., Lebok, P., Clauditz, T. S., Jacobsen, F., Izbicki, J. R., Jansen, K., Sauter, G., Uhlig, R., Wilczak, W., Steurer, S., Minner, S., Burandt, E., Krech, R. H., Dum, D., Krech, T., Marx, A. H. & Simon, R., 07.04.2021, In: BIOMEDICINES. 9, 4, 397.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness
Jansen, K., Büscheck, F., Moeller, K., Kluth, M., Hube-Magg, C., Blessin, N. C., Perez, D., Izbicki, J., Neipp, M., Mofid, H., Daniels, T., Nahrstedt, U., Fraune, C., Jacobsen, F., Bernreuther, C., Lebok, P., Sauter, G., Uhlig, R., Wilczak, W., Simon, R., Steurer, S., Burandt, E., Marx, A., Krech, T. & Clauditz, T., 2021, In: PEERJ. 9, e11905.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer
Bonk, S., Kluth, M., Jansen, K., Hube-Magg, C., Makrypidi-Fraune, G., Höflmayer, D., Weidemann, S., Möller, K., Uhlig, R., Büscheck, F., Luebke, A. M., Burandt, E., Clauditz, T. S., Steurer, S., Schlomm, T., Huland, H., Heinzer, H., Sauter, G., Simon, R. & Dum, D., 09.2020, In: PROSTATE. 80, 13, p. 1097-1107 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review